In focus · trending topic

AXSM

21 stories · following the connections

Axsome Therapeutics Reports First Quarter 2017 Financial Results

By Nasdaq OMXMay 9, 2017, 11:02 AM UTC

Axsome Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

By Nasdaq OMXMar 7, 2017, 9:35 PM UTC

Axsome Therapeutics to Present at Biotech Showcase 2017

By Nasdaq OMXJan 4, 2017, 12:00 PM UTC

Axsome Therapeutics Receives FDA Clearance of IND for Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agitation

By Nasdaq OMXJan 3, 2017, 12:01 PM UTC

Axsome Therapeutics Receives FDA Clearance of IND for Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agitation

By Nasdaq OMXJan 3, 2017, 12:01 PM UTC

Axsome Therapeutics Reports Third Quarter 2016 Financial Results

By Nasdaq OMXNov 14, 2016, 9:30 PM UTC

Axsome Therapeutics Enters into $20 Million Term Loan Agreement with Silicon Valley Bank

By Nasdaq OMXNov 10, 2016, 12:01 PM UTC

Axsome Therapeutics Enters into $20 Million Term Loan Agreement with Silicon Valley Bank

By Nasdaq OMXNov 10, 2016, 12:01 PM UTC